Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term [Yahoo! Finance]
Why Hall Of Famer Terrell Davis Is Talking About The ‘Other TD' [Forbes]
With 72% ownership in Teva Pharmaceutical Industries Limited (NYSE:TEVA), institutional investors have a lot riding on the business [Yahoo! Finance]
Is Teva a Bargain After 27% Surge and Cost-Cutting Headlines? [Yahoo! Finance]